lasid_logo.png

Welcome to LASID!

Latin American Society for Immunodeficiencies. Uniting Latin America in the pursuit of excellence in immunodeficiency research and care.
Learn more about our mission here.

Rectangle-39.png

Join the LASID Community Today!

Take advantage of a range of benefits when you become a member of LASID (Latin American Society for Immunodeficiencies). Be part of a vibrant, collaborative community committed to advancing immunodeficiency research and care.
Copia de REPORTE 2025 lasid (1)
lasid wednesdayt 26th (2)
LASID PINT
The Lung in Inborn Errors of Immunity: From Clinical Disease Patterns to Molecular Pathogenesis
Diseño sin título
Group 236
Group 239 (1)

Journal of Human Immunity (JHI) – Official LASID Publication

Are you working on cutting-edge research in immunology?
Submit your manuscript to JHI – the Journal of Human Immunity, LASID’s official peer-reviewed journal dedicated to advancing the field of primary immunodeficiencies and human immunity.

LASID members receive exclusive discounts on both access and publication fees.
Whether you’re reading the latest studies or publishing your own, membership pays off.

📖 Read the Journal
✍️ Submit Your Paper
🔗 Become a LASID Member

Advance science. Share knowledge. Join the LASID community.

Next Events

There are no upcoming events at this time

Patients and health policy organizations

Iniciativa ALAS

ALAS is an alliance of associations across countries dedicated to ensuring the right to health for individuals with primary immunodeficiencies. By fostering collaboration and advocacy, ALAS plays a pivotal role in shaping health policy, aiming to improve access to care and support for those affected by these conditions. Through its efforts, the initiative seeks to create a unified voice that influences health policy, ensuring that the needs of individuals with primary immunodeficiencies are recognized and addressed at both national and international levels.

IPOPI

IPOPI is a non-profit international organisation and the leading advocate for primary immunodeficiency (PID) patients worldwide working in collaboration with patients, doctors, politicians, regulators, pharmaceutical industry and other relevant stakeholders. para garantizar el derecho a la salud a personas con inmunodeficiencias primarias

Check our Transplant Group sessions available on LASID.

Scroll to Top